Back to company

EPITHERAPEUTICS ApS: Financial statements 2014

CVR: 30523067

EPITHERAPEUTICS ApS (CVR 30523067) has filed annual accounts for 2014. In 2014, the company reported a gross profit of DKK -28,615,909 and a net result of DKK -39,333,433 compared with DKK -34,462,624 the year before. Equity amounted to DKK 55,979,930. The solvency ratio was 84.9%.

Gross Profit
-28,615,909 kr.
Profit/Loss
-39,333,433 kr.
Equity
55,979,930 kr.
Total Assets
65,936,230 kr.

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2014--28.6 mio.-39.3 mio.56 mio.-
2013--20.7 mio.-34.5 mio.15.7 mio.-
2012--11.9 mio.-26.6 mio.-9.1 mio.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on EPITHERAPEUTICS ApS

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2014

Søren Møller joins the board of EPITHERAPEUTICS ApSSep 4, 2014

As of September 4, 2014, Søren Møller has joined the board of directors of EPITHERAPEUTICS ApS.

Henrijette Elsebeth Richter leaves the board of EPITHERAPEUTICS ApSSep 4, 2014

As of September 4, 2014, Henrijette Elsebeth Richter has left the board of directors of EPITHERAPEUTICS ApS.

EPITHERAPEUTICS ApS: The 2013 annual report is outMay 30, 2014

EPITHERAPEUTICS ApS has published its annual report for 2013. Gross profit came to DKK -20,667,009, and the net result was DKK -34,462,624.

Kapil Dhingra joins the board of EPITHERAPEUTICS ApSFeb 3, 2014

As of February 3, 2014, Kapil Dhingra has joined the board of directors of EPITHERAPEUTICS ApS.

About EPITHERAPEUTICS ApS

EPITHERAPEUTICS ApS was a Danish company of the type Anpartsselskab based in København Ø, founded in 2008 and dissolved in 2023. The company was registered under the industry Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company has 1 employee. In 2021, the company reported a gross profit of DKK 72,058 and a net result of DKK -21,073,661 compared with DKK -3,028,693 the year before. Equity amounted to DKK 9,205,571.